vTv Therapeutics Inc.
- VTVT
- NASDAQ
- Biotechnology
- Diabetes Therapeutics
- Clinical-Stage Biopharma
$26.54
Today −3.81%Quote Oct 16, 2026, 08:00 PM UTC
−15.48%over the last month
Max drawdown −16.7%From 1-month high −16.7%3 months −18.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$329.3M
Approximate share count
Next earnings
Nov 5
Expected, not confirmed
Analyst target
$42.00
+58.3% from here
Floor
—
Data unavailable
Where the price sits
No analyst target range for this stock.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about VTVTPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
26